Amgen (HKSE:04332) Inventories, Raw Materials & Components: HK$8,480 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:04332 Amgen Inc HKSE:04332
79 GF Score
Price HK$1,761.00
GF Value HK$1,463.66
! 8 Warning Signs
View Full Analysis

What is Amgen Inventories, Raw Materials & Components?

Amgen HKSE:04332 79 Inventories, Raw Materials & Components is HK$8,480 Mil as of Jun. 2026. GuruFocus rates HKSE:04332 with a GF Score™ of 79/100 and a GF Value™ of HK$1,463.66. The stock has 8 warning signs investors should review.

Amgen's inventories, raw materials & components for the quarter that ended in Jun. 2026 was HK$8,480 Mil.

Amgen's quarterly raw materials increased from Dec. 2025 (HK$7,119 Mil) to Mar. 2026 (HK$8,202 Mil) and increased from Mar. 2026 (HK$8,202 Mil) to Jun. 2026 (HK$8,480 Mil).

Amgen's annual raw materials declined from Dec. 2023 (HK$7,755 Mil) to Dec. 2024 (HK$6,359 Mil) but then increased from Dec. 2024 (HK$6,359 Mil) to Dec. 2025 (HK$7,119 Mil).

Amgen Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Amgen's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amgen Inventories, Raw Materials & Components Chart

Amgen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,045.95 6,446.31 7,755.13 6,358.64 7,119.43

Amgen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,946.01 7,434.39 7,119.43 8,202.49 8,480.39
HKSE:04332
79GF Score
Amgen Inc HKSE:04332
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amgen Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$8,480 Mil mean?
Amgen (HKSE:04332) has a Inventories, Raw Materials & Components of HK$8,480 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Amgen and its competitors.
Is Amgen's Inventories, Raw Materials & Components too high?
Amgen's current Inventories, Raw Materials & Components is HK$8,480 Mil. Overall, Amgen has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Amgen's Inventories, Raw Materials & Components compare to GILD and PFE?
Amgen's Inventories, Raw Materials & Components of HK$8,480 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Amgen and its competitors. Amgen's current Inventories, Raw Materials & Components is HK$8,480 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amgen stock overvalued right now?
Amgen (HKSE:04332) has a current Inventories, Raw Materials & Components of HK$8,480 Mil. The stock's GF Value™ is HK$1,463.66, compared to a current price of HK$1,761.00 — trading 20.3% above its estimated fair value. The current Inventories, Raw Materials & Components is HK$8,480 Mil. Amgen's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Amgen (HKSE:04332), the current Inventories, Raw Materials & Components is HK$8,480 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amgen (HKSE:04332) Overvalued in 2026?

Based on GuruFocus' analysis, Amgen stock appears to be overvalued. The current stock price of HK$1,761.00 is trading 20.3% above its estimated GF Value™ of HK$1,463.66.

Key valuation signals for HKSE:04332:

  • Inventories, Raw Materials & Components: HK$8,480 Mil
  • GF Value™: HK$1,463.66 vs. price of HK$1,761.00 (20.3% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the HKSE:04332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amgen Business Description

Address One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
79GF Score

Get the complete analysis for HKSE:04332

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1,761.00
Price
HK$1,463.66
GF Value